ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $96,327 | $39,625 | $37,438 | $35,777 |
| - Cash | $1,661 | $1,237 | $1,100 | $1,069 |
| + Debt | $1,716 | $1,668 | $1,700 | $1,796 |
| Enterprise Value | $96,382 | $40,057 | $38,038 | $36,504 |
| Revenue | $234 | $157 | $824 | $79 |
| % Growth | 48.9% | -81% | 939% | – |
| Gross Profit | $212 | $143 | $809 | $67 |
| % Margin | 90.7% | 91.1% | 98.2% | 84.4% |
| EBITDA | -$514 | -$528 | $230 | -$493 |
| % Margin | -219.9% | -336.8% | 27.9% | -621.4% |
| Net Income | -$591 | -$568 | $163 | -$523 |
| % Margin | -252.8% | -362.3% | 19.8% | -660% |
| EPS Diluted | -1.73 | -1.82 | 0.55 | -1.8 |
| % Growth | 4.9% | -430.9% | 130.6% | – |
| Operating Cash Flow | $0 | $243 | -$354 | -$358 |
| Capital Expenditures | $0 | -$8 | -$17 | -$12 |
| Free Cash Flow | $0 | $235 | -$371 | -$370 |